当前位置: X-MOL 学术Antivir. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Highlights of the 30th International Conference on Antiviral Research
Antiviral Research ( IF 7.6 ) Pub Date : 2017-08-01 , DOI: 10.1016/j.antiviral.2017.07.017
Graciela Andrei , Kara Carter , Zlatko Janeba , Aruna Sampath , Luis M. Schang , E. Bart Tarbet , R. Anthony Vere Hodge , Mike Bray , José A. Esté

The 30th International Conference on Antiviral Research (ICAR) was held in Atlanta, GA, USA from May 18 to 21, 2017. This report provides an account of award lectures, invited keynote addresses and oral presentations during the meeting. The 2017 Gertrude Elion Memorial Lecture Award by Michael Sofia highlighted one of the most important accomplishments in recent drug discovery in antiviral research, the identification of the hepatitis C virus direct-acting antiviral sofosbuvir and new alternatives to combat hepatitis B virus (HBV) infection. The Antonín Holý Lecture Award by David Chu on medicinal chemistry provided an overview of early developments of nucleoside analogs for the treatment of HIV and varicella zoster virus infection and how this knowledge serves to develop new drugs targeting HBV. Priscilla Yang gave the first ISAR Women in Science lecture. She reported on pharmacological validation of new antiviral targets for dengue, Zika and other flaviviruses. The William Prusoff Young Investigator Lecture Award by Maaike Everts described the Alabama Drug Discovery Alliance and the Antiviral Drug Discovery and Development Consortium, and how they are helping to accelerate the development of new antivirals. The 30th ICAR was a success in promoting new discoveries in antiviral drug development and research. The 31st ICAR will be held in Porto, Portugal, June 11–15, 2018.



中文翻译:

第三十届国际抗病毒研究会议摘要

第30届国际抗病毒研究会议(ICAR)于2017年5月18日至21日在美国乔治亚州亚特兰大举行。该报告提供了会议上的获奖演讲,邀请主题演讲和口头报告。迈克尔·索菲亚(Michael Sofia)于2017年获得格特鲁德·艾利安(Gertrude Elion)纪念演讲奖,该奖项重点介绍了抗病毒研究中最近药物发现中最重要的成就之一,即丙型肝炎病毒直接作用的抗病毒药物索非布韦的鉴定以及对抗乙肝病毒(HBV)感染的新替代品。David Chu关于药物化学的AntonínHolý演讲奖概述了用于治疗HIV和水痘带状疱疹病毒感染的核苷类似物的早期开发,以及该知识如何用于开发针对HBV的新药物。杨sc琳(Priscilla Yang)举办了第一届ISAR女科学讲座。她报道了针对登革热,寨卡病毒和其他黄病毒的新抗病毒靶标的药理学验证。Maaike Everts颁发的William Prusoff青年研究者演讲奖描述了阿拉巴马州的药物发现联盟和抗病毒药物发现与开发联合会,以及它们如何帮助加速新抗病毒药物的开发。第30届ICAR在促进抗病毒药物开发和研究的新发现方面取得了成功。第31届ICAR将于2018年6月11日至15日在葡萄牙波尔图举行。Maaike Everts颁发的William Prusoff青年研究者演讲奖描述了阿拉巴马州的药物发现联盟和抗病毒药物发现与开发联合会,以及它们如何帮助加速新抗病毒药物的开发。第30届ICAR在促进抗病毒药物开发和研究的新发现方面取得了成功。第31届ICAR将于2018年6月11日至15日在葡萄牙波尔图举行。Maaike Everts颁发的William Prusoff青年研究者演讲奖描述了阿拉巴马州的药物发现联盟和抗病毒药物发现与开发联合会,以及它们如何帮助加速新抗病毒药物的开发。第30届ICAR在促进抗病毒药物开发和研究的新发现方面取得了成功。第31届ICAR将于2018年6月11日至15日在葡萄牙波尔图举行。

更新日期:2017-08-01
down
wechat
bug